US 11229681
Dominant-negative FGF2 antagonists
granted A61KA61K38/1825A61P
Quick answer
US patent 11229681 (Dominant-negative FGF2 antagonists) held by The Regents of the University of California expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/1825, A61P, A61P35/00